Skip to main content

Advertisement

Log in

Clinical characteristics of infections caused by Mycoplasma pneumoniae P1 genotypes in children

  • Original Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Mycoplasma pneumoniae (M. pneumoniae) isolates can be classified into two major genetic groups, P1 type 1 (MP1) and P1 type 2 (MP2), based on the DNA sequence of the P1 adhesion protein gene. The aim of our study was to determine if M. pneumoniae P1 genotype is associated with disease manifestation and severity of acute M. pneumoniae infection. We compared epidemiological and clinical data of children infected with either MP1 or MP2. In addition, we separately analysed data of patients presenting with individual manifestations of M. pneumoniae infection. Data of 356 patients infected with MP1 were compared with those of 126 patients infected with MP2. MP2-infected children presented with higher median baseline C-reactive protein levels and were admitted to the hospital more often. The distribution of P1 genotype varied among groups of patients with different manifestations of M. pneumoniae infection. MP2 was more common than MP1 among patients with neurological and cardiovascular manifestations, whereas MP1 was more prevalent in other manifestations. The results from our large cohort indicate that the two P1 subtypes may have different pathogenic potential and that infections with MP2 strains could be more virulent than those with MP1 strains.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Atkinson TP, Waites KB (2014) Mycoplasma pneumoniae infections in childhood. Pediatr Infect Dis J 33(1):92–94. https://doi.org/10.1097/INF.0000000000000171

    Article  PubMed  Google Scholar 

  2. Krause DC, Leith DK, Wilson RM, Baseman JB (1982) Identification of Mycoplasma pneumoniae proteins associated with hemadsorption and virulence. Infect Immun 35(3):809–817

    PubMed  PubMed Central  CAS  Google Scholar 

  3. Balish MF, Krause DC (2006) Mycoplasmas: a distinct cytoskeleton for wall-less bacteria. J Mol Microbiol Biotechnol 11(3–5):244–255

    Article  PubMed  CAS  Google Scholar 

  4. Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP (2017) Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev 30(3):747–809. https://doi.org/10.1128/CMR.00114-16

    Article  PubMed  PubMed Central  Google Scholar 

  5. Cousin-Allery A, Charron A, de Barbeyrac B, Fremy G, Skov Jensen J, Renaudin H et al (2000) Molecular typing of Mycoplasma pneumoniae strains by PCR-based methods and pulsed-field gel electrophoresis. Application to French and Danish isolates. Epidemiol Infect 124(1):103–111

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Kogoj R, Mrvic T, Praprotnik M, Kese D (2015) Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014. Euro Surveill 20(37). doi:https://doi.org/10.2807/1560-7917.ES.2015.20.37.30018

  7. Waites KB (2003) New concepts of Mycoplasma pneumoniae infections in children. Pediatr Pulmonol 36(4):267–278

    Article  PubMed  Google Scholar 

  8. Narita M (2016) Classification of extrapulmonary manifestations due to Mycoplasma pneumoniae infection on the basis of possible pathogenesis. Front Microbiol 7:23. https://doi.org/10.3389/fmicb.2016.00023

    Article  PubMed  PubMed Central  Google Scholar 

  9. Sánchez-Vargas FM, Gómez-Duarte OG (2008) Mycoplasma pneumoniae—an emerging extra-pulmonary pathogen. Clin Microbiol Infect 14(2):105–117

    Article  PubMed  Google Scholar 

  10. Cizman M, Beovic B, Marolt-Gomiscek M, Seme K (2013) Kako predpisujemo protimikrobna zdravila v bolnišnicah, 2nd edition. Ljubljana

  11. Kim KW, Sung JJ, Tchah H, Ryoo E, Cho HK, Sun YH et al (2015) Hepatitis associated with Mycoplasma pneumoniae infection in Korean children: a prospective study. Korean J Pediatr 58(6):211–217. https://doi.org/10.3345/kjp.2015.58.6.211

    Article  PubMed  PubMed Central  Google Scholar 

  12. Krause DC, Baseman JB (1983) Inhibition of Mycoplasma pneumoniae hemadsorption and adherence to respiratory epithelium by antibodies to a membrane protein. Infect Immun 39(3):1180–1186

    PubMed  PubMed Central  CAS  Google Scholar 

  13. Baseman JB, Cole RM, Krause DC, Leith DK (1982) Molecular basis for cytadsorption of Mycoplasma pneumoniae. J Bacteriol 151(3):1514–1522

    PubMed  PubMed Central  CAS  Google Scholar 

  14. Bredt W (1968) Motility and multiplication of Mycoplasma pneumoniae. A phase contrast study. Pathol Microbiol 32(6):321–326

    CAS  Google Scholar 

  15. Hasselbring BM, Page CA, Sheppard ES, Krause DC (2006) Transposon mutagenesis identifies genes associated with Mycoplasma pneumoniae gliding motility. J Bacteriol 188(17):6335–6345. https://doi.org/10.1128/JB.00698-06

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Prince OA, Krunkosky TM, Krause DC (2014) In vitro spatial and temporal analysis of Mycoplasma pneumoniae colonization of human airway epithelium. Infect Immun 82(2):579–586. https://doi.org/10.1128/IAI.01036-13

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Kornspan JD, Tarshis M, Rottem S (2011) Adhesion and biofilm formation of Mycoplasma pneumoniae on an abiotic surface. Arch Microbiol 193(11):833–836. https://doi.org/10.1007/s00203-011-0749-y

    Article  PubMed  CAS  Google Scholar 

  18. Simmons WL, Daubenspeck JM, Osborne JD, Balish MF, Waites KB, Dybvig K (2013) Type 1 and type 2 strains of Mycoplasma pneumoniae form different biofilms. Microbiology 159(4):737–747. https://doi.org/10.1099/mic.0.064782-0

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Lluch-Senar M, Cozzuto L, Cano J, Delgado J, Llórens-Rico V, Pereyre S et al (2015) Comparative “-omics” in Mycoplasma pneumoniae clinical isolates reveals key virulence factors. PLoS One 10(9):e0137354

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Techasaensiri C, Tagliabue C, Cagle M, Iranpour P, Katz K, Kannan TR et al (2010) Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among Mycoplasma pneumoniae strains. Am J Respir Crit Care Med 182(6):797–804

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Fan L, Li D, Zhang L, Hao C, Sun H, Shao X et al (2017) Pediatric clinical features of Mycoplasma pneumoniae infection are associated with bacterial P1 genotype. Exp Ther Med 14(3):1892–1898

    Article  PubMed  PubMed Central  Google Scholar 

  22. Zhao F, Lv M, Tao X, Huang H, Zhang B, Zhang Z et al (2012) Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China. Antimicrob Agents Chemother 56(2):1108–1109

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Nilsson AC, Björkman P, Welinder-Olsson C, Widell A, Persson K (2010) Clinical severity of Mycoplasma pneumoniae (MP) infection is associated with bacterial load in oropharyngeal secretions but not with MP genotype. BMC Infect Dis 10:39

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Henrickson SE, Manne S, Dolfi DV, Mansfield KD, Parkhouse K, Mistry RD et al (2018) Genomic circuitry underlying immunological response to pediatric acute respiratory infection. Cell Rep 22(2):411–426. https://doi.org/10.1016/j.celrep.2017.12.043

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Goulding J, Snelgrove R, Saldana J, Didierlaurent A, Cavanagh M, Gwyer E et al (2007) Respiratory infections: do we ever recover? Proc Am Thorac Soc 4(8):618–625

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Robnik B, Kese D, Rojko T, Horvat-Ledinek A, Praznikar A, Beovic B (2017) Unilateral brachial plexopathy, a rare complication of Mycoplasma pneumoniae infection. J Infect Chemother. https://doi.org/10.1016/j.jiac.2017.11.008

  27. Narita M (2010) Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J Infect Chemother 16(3):162–169. https://doi.org/10.1007/s10156-010-0044-x

    Article  PubMed  Google Scholar 

  28. Chergui K, Fourme T, Baron AV, Loubieres Y, Voyer C, Jardin F (1998) Mycoplasma pneumoniae and second-degree heart block. Clin Infect Dis 27(6):1534–1535

    Article  PubMed  CAS  Google Scholar 

  29. Dumke R, Schurwanz N, Jacobs E (2008) Characterisation of subtype and variant-specific antigen regions of the P1 adhesin of Mycoplasma pneumoniae. Int J Med Microbiol 298:483–491. https://doi.org/10.1016/j.ijmm.2007.06.002

    Article  PubMed  CAS  Google Scholar 

  30. Qu J, Yu X, Liu Y, Yin Y, Gu L, Cao B et al (2013) Specific multilocus variable-number tandem-repeat analysis genotypes of Mycoplasma pneumoniae are associated with diseases severity and macrolide susceptibility. PLoS One 8(12):e82174. https://doi.org/10.1371/journal.pone.0082174

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jasna Rodman Berlot or Darja Keše.

Ethics declarations

The authors declare that ethical approval was not required. The study was performed only by using remnants of specimens that had initially been collected for diagnostic purposes. All samples from patients included in the study were rendered anonymous. The patients were registered with an encrypted number code. Therefore, individuals could not be matched with their samples and their epidemiological and clinical data. The study was conducted according to the principles expressed in the Declaration of Helsinki, the Oviedo Convention on Human Rights and Biomedicine and the Slovene Code of Medical Deontology. Since no additional samples or data were collected, the study was deemed to be low risk and the need for additional ethical permission from the National Medical Ethics Committee was waived.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rodman Berlot, J., Krivec, U., Praprotnik, M. et al. Clinical characteristics of infections caused by Mycoplasma pneumoniae P1 genotypes in children. Eur J Clin Microbiol Infect Dis 37, 1265–1272 (2018). https://doi.org/10.1007/s10096-018-3243-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-018-3243-5

Keywords

Navigation